Mangoceuticals (MGRX) Non-Current Assets (2022 - 2026)

Mangoceuticals has disclosed Non-Current Assets across 5 years of filings, most recently posting $13.9 million for Q2 2026.

• In Q2 2026, Non-Current Assets fell 32.8% year-over-year to $13.9 million; the TTM figure through Jun 2026 stood at $13.9 million (down 32.8% YoY), while the FY2025 annual figure was $14.5 million, down 4.92% from the prior year.
• Non-Current Assets came in at $13.9 million for Q2 2026 at Mangoceuticals, down from $14.2 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $21.6 million in Q1 2025 to a low of $211639.0 in Q1 2024.
• Average Non-Current Assets over 5 years is $9.8 million, with a median of $14.2 million recorded in 2026.
• Year-over-year, Non-Current Assets soared 10095.29% in 2025 and slumped 34.02% in 2026.
• Over 5 years, Non-Current Assets stood at $308682.0 in 2022, then plunged by 30.22% to $215391.0 in 2023, then jumped by 7001.0% to $15.3 million in 2024, then slipped by 4.92% to $14.5 million in 2025, then dropped by 4.23% to $13.9 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $13.9 million in Q2 2026, $14.2 million in Q1 2026, and $14.5 million in Q4 2025.